Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-07-23, Stock:JNJ, The news for the past five days is as follows:
2018-07-16: NEWS1: Day Ahead: Top 3 Things to Watch.NEWS2: Johnson & Johnson (JNJ) Slips 1.1% Ahead of Earnings: What To Watch.NEWS3: Johnson & Johnson (JNJ) Slips 1.1% Ahead of Earnings: What To Watch.NEWS4: Pacira Focused on Exparel Development Amid Competition.NEWS5: Pacira Focused on Exparel Development Amid Competition.NEWS6: Thai Shares May See Continued Selling Pressure.NEWS7: Thai Shares May See Continued Selling Pressure.NEWS8: Indonesia Bourse May Extend Monday's Losses.NEWS9: Indonesia Bourse May Extend Monday's Losses.NEWS10: Pacira Focused on Exparel Development Amid Competition.NEWS11: Johnson & Johnson Q2 Earnings Preview.NEWS12: Hong Kong Bourse Due For Profit Taking.NEWS13: Hong Kong Bourse Due For Profit Taking.NEWS14: Johnson & Johnson (JNJ) Slips 1.1% Ahead of Earnings: What To Watch.NEWS15: Losing Streak May Continue For China Stock Market.NEWS16: Losing Streak May Continue For China Stock Market.NEWS17: Taiwan Shares May Open Under Pressure.NEWS18: Taiwan Shares May Open Under Pressure.NEWS19: Pre-Market Earnings Report for July 17, 2018 :  JNJ, UNH, GS, SCHW, PLD, PGR, OMC, CMA, FHN, NEOG, NSM, MBWM.NEWS20: Pre-Market Earnings Report for July 17, 2018 :  JNJ, UNH, GS, SCHW, PLD, PGR, OMC, CMA, FHN, NEOG, NSM, MBWM.NEWS21: Losses May Accelerate For Singapore Stock Market.NEWS22: Losses May Accelerate For Singapore Stock Market.NEWS23: 10 Dow Jones Titans to Buy Now.NEWS24: Malaysia Bourse Overdue For Downside Correction.NEWS25: Malaysia Bourse Overdue For Downside Correction.NEWS26: Does the $4.7 Billion Talc Verdict Spell Trouble for J&J?.NEWS27: Does the $4.7 Billion Talc Verdict Spell Trouble for J&J?.NEWS28: South Korea Shares May Take Further Damage.NEWS29: South Korea Shares May Take Further Damage.NEWS30: Johnson & Johnson earnings: Time to talk about drug prices.NEWS31: Daily Dividend Report: SJM, NNN, CPG, JNJ, PEP.NEWS32: Daily Dividend Report: SJM, NNN, CPG, JNJ, PEP.NEWS33: J&J's (JNJ) Invokana Label Expansion Filing Hit by FDA Delay.NEWS34: J&J's (JNJ) Invokana Label Expansion Filing Hit by FDA Delay.NEWS35: Does the $4.7 Billion Talc Verdict Spell Trouble for J&J?.NEWS36: Major Averages Close Mixed Following Lackluster Session - U.S. Commentary.NEWS37: Major Averages Close Mixed Following Lackluster Session - U.S. Commentary.NEWS38: Company News For Jul 16, 2018.NEWS39: Company News For Jul 16, 2018.NEWS40: Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2018.NEWS41: J&J&apos;s (JNJ) Invokana Label Expansion Filing Hit by FDA Delay.NEWS42: What to Expect from J&J’s Consumer Business in Q2 2018.NEWS43: Earnings Preview: Healthcare Giant Johnson & Johnson Set To Report Tuesday Morning.NEWS44: The World Cup of Dividend Stocks: 8 of the Most Dependable Dividends.NEWS45: The Zacks Analyst Blog Highlights: Johnson & Johnson, Novartis, UnitedHealth and Microsoft.NEWS46: The Zacks Analyst Blog Highlights: Johnson & Johnson, Novartis, UnitedHealth and Microsoft.NEWS47: Add Up The Parts: DIVB Could Be Worth $29.NEWS48: Add Up The Parts: DIVB Could Be Worth $29.NEWS49: 5 Top Stock Trades for Monday — Buy Netflix Ahead of Earnings?.NEWS50: 5 Top Stock Trades for Monday — Buy Netflix Ahead of Earnings?.NEWS51: Company News For Jul 16, 2018.NEWS52: Round Two Of Bank Earnings Coming Up With Bank of America, Goldman Sachs And Morgan Stanley.NEWS53: Will Pharmaceuticals Keep Fueling J&J’s Performance in Q2 2018?.NEWS54: Stocks Continue To Experience Choppy Trading - U.S. Commentary.NEWS55: Stocks Continue To Experience Choppy Trading - U.S. Commentary.NEWS56: Today's Research Reports on Stocks to Watch: Biocept and Johnson and Johnson.NEWS57: The Zacks Analyst Blog Highlights: Johnson & Johnson, Novartis, UnitedHealth and Microsoft.NEWS58: Johnson & Johnson: Increase in Operating Margin in Q2 2018?.NEWS59: Stocks Turning In Lackluster Performance In Morning Trading - U.S. Commentary.NEWS60: Stocks Turning In Lackluster Performance In Morning Trading - U.S. Commentary.NEWS61: 5 Top Stock Trades for Monday — Buy Netflix Ahead of Earnings?.NEWS62: Stocks May Show A Lack Of Direction In Early Trading - U.S. Commentary.NEWS63: Stocks May Show A Lack Of Direction In Early Trading - U.S. Commentary.
2018-07-17: NEWS1: What Happened in the Stock Market Today.NEWS2: What Happened in the Stock Market Today.NEWS3: Jim Cramer: A Pretty Wild Rally In Three Oppositional Groups.NEWS4: These Companies are Earnings All-Stars.NEWS5: These Companies are Earnings All-Stars.NEWS6: Nasdaq Hits Record High as Amazon Pops.NEWS7: Nasdaq Hits Record High as Amazon Pops.NEWS8: J&J's (JNJ) Phase III Study for Invokana Halted Earlier.NEWS9: J&J's (JNJ) Phase III Study for Invokana Halted Earlier.NEWS10: British pharma company Eusa set to unveil deal with giant Johnson & Johnson.NEWS11: What Happened in the Stock Market Today.NEWS12: After the Bell: Dow Rises 56 Points as Stocks Keep Chugging Higher.NEWS13: US companies are shipping goods before they're hit with tariffs: report.NEWS14: MedPlast Holdings, Inc. -- Moody's assigns B2 CFR to MedPlast Holdings, Inc..NEWS15: Market Close Report: Historical high reached as NASDAQ Composite Index closes at 7,855.12..NEWS16: Market Close Report: Historical high reached as NASDAQ Composite Index closes at 7,855.12..NEWS17: Close Update: Wall Street Bounces Back From Netflix Crash on Powell Assurances.NEWS18: Close Update: Wall Street Bounces Back From Netflix Crash on Powell Assurances.NEWS19: Johnson & Johnson climbs while Netflix and UnitedHealth slip.NEWS20: US STOCKS-Wall St climbs on Powell comments, earnings.NEWS21: Health Care Sector Update for 07/17/2018: OPK,PULM,JNJ,CANF.NEWS22: Health Care Sector Update for 07/17/2018: OPK,PULM,JNJ,CANF.NEWS23: J&J Vows to Fight Verdict Linking Baby Powder to Ovarian Cancer.NEWS24: Dow marks 4th straight gain as stocks finish broadly higher after Powell testimony.NEWS25: Markets Right Now: Tech, health care lead gains for stocks.NEWS26: Tuesday Sector Leaders: Materials, Healthcare.NEWS27: Tuesday Sector Leaders: Materials, Healthcare.NEWS28: J&J&apos;s (JNJ) Phase III Study for Invokana Halted Earlier.NEWS29: Dow, S&P 500 on Pace for best month since January.NEWS30: 5 Top Stock Trades for Wednesday Morning.NEWS31: US stocks rise as retailers and smaller companies climb.NEWS32: US STOCKS-Wall St gains on Powell comments, rosy earnings expectations.NEWS33: Health Care Sector Update for 07/17/2018: PULM,JNJ,CANF.NEWS34: Health Care Sector Update for 07/17/2018: PULM,JNJ,CANF.NEWS35: A Full Scale Dow Component Blitz.NEWS36: US STOCKS-Wall St gains on Powell comments, J&J results; Netflix drags.NEWS37: J&J Nears Sale of Sylvant to U.K. Drugmaker Eusa Pharma.NEWS38: J&J beats quarterly expectations on drug sales surge, shares jump.NEWS39: Johnson & Johnson (JNJ) Q2 2018 Earnings Conference Call Transcript.NEWS40: [$$] Johnson & Johnson's Pharma Business Fuels Sales Growth.NEWS41: J&J Earnings: No More Tears?.NEWS42: US STOCKS-J&J, Powell comment push Wall St higher; Netflix weighs.NEWS43: Markets Right Now: After an early wobble, stocks turn higher.NEWS44: Johnson & Johnson beats revenue, profit projections for 2Q.NEWS45: Is Johnson & Johnson Worth Another Look After Its Earnings Victory?.NEWS46: When Will This Stock Market Bubble Burst in Our Faces? Not Anytime Soon..NEWS47: Jim Cramer on Netflix, Goldman Sachs, Bank of America and Johnson & Johnson.NEWS48: Johnson & Johnson profit beat fueled by strength in pharma business.NEWS49: J&J&apos;s (JNJ) Q2 Earnings Beat on Higher Cancer Drug Sales.NEWS50: Johnson & Johnson CEO defends drug prices, calls for changes in how medical costs are covered.NEWS51: Johnson & Johnson CEO defends drug prices, calls for changes in how medical costs are covered.NEWS52: Johnson & Johnson shares rose 3.7% on Q2 earnings, revenue beats.NEWS53: Watch Out For Goldman.NEWS54: US indexes dip as Netflix plunge hurts tech, consumer stocks.NEWS55: Markets Now: Dow Slips 12 Points, as UnitedHealth Slides.NEWS56: Markets Now: Dow Slips 12 Points, as UnitedHealth Slides.NEWS57: Goldman Beats in Blankfein&apos;s Final Quarter.NEWS58: How Johnson & Johnson Became A Household Name.NEWS59: Markets Right Now: Tech stocks lead US indexes lower.NEWS60: J&J (JNJ) Ordered to Pay $4.69 Billion in Talc Lawsuit (Revised).NEWS61: Dow on the verge of snapping a 3-day rally as tech slumps, investors wait for Powell testimony.NEWS62: Is Johnson & Johnson a Buy?.NEWS63: Morning Movers: Johnson & Johnson Gains; Deere, Caterpillar Slip.NEWS64: Stocks to Watch: Goldman Sachs, Netflix, Amazon, J&J, UnitedHealth, Walmart, Ford, Omnicom, Redfin.NEWS65: Markets Now: Dow Slips 12 Points, as Goldman Sachs, UnitedHealth Slide.NEWS66: US STOCKS-Futures dip as Netflix weighs; Powell testimony eyed.NEWS67: Top 5 Things To Know In The Market On Tuesday.NEWS68: Benzinga's Daily Biotech Pulse: Bellicum CFO Resigns, Roche's Trial Meets Endpoints, Avid Bioservices Turns To Black In Q4.NEWS69: Johnson & Johnson beats revenue, profit projections for 2Q.NEWS70: J&J (JNJ) Down on Trimmed View Despite Q2 Earnings Beat.NEWS71: Johnson & Johnson Reports Strong Second-Quarter Results.NEWS72: Goldman Sachs posts 2Q earnings beat.NEWS73: J&J CFO Says 2Q Results 'Not Related to Trade Wars'.NEWS74: J&J CFO Says 2Q Results 'Not Related to Trade Wars'.NEWS75: Stocks Drift, Oil Steadies, Dollar Dips as Investors Question Growth Prospects.NEWS76: Stocks making the biggest move premarket: NFLX, UNH, GS, AMZN, WMT & more.NEWS77: Johnson & Johnson’s Medical Device Business: Q2 2018 Estimates.NEWS78: Johnson & Johnson reports Q2 earnings, revenue beats.NEWS79: Tech stock tumble could be ahead after Netflix miss.NEWS80: Johnson & Johnson CFO on Q2 earnings beat.NEWS81: Earnings Reaction History: Johnson & Johnson, 72.7% Follow-Through Indicator, 2.5% Sensitive.NEWS82: Earnings Reaction History: Johnson & Johnson, 72.7% Follow-Through Indicator, 2.5% Sensitive.NEWS83: Johnson & Johnson Reports 2018 Second-Quarter Results:.NEWS84: Johnson & Johnson to Host Earnings Call.NEWS85: Pharma fuels Johnson & Johnson's earnings beat, consumer lags.NEWS86: Johnson & Johnson tops earnings, revenue estimates.NEWS87: Johnson & Johnson (JNJ) Is Climbing On Better Than Expected Q2 Profit.NEWS88: Johnson & Johnson (JNJ) Is Climbing On Better Than Expected Q2 Profit.NEWS89: Marlborough&apos;s CeQur revives expansion plans after buying J&J insulin device.NEWS90: Stocks May Open Roughly Flat Ahead Of Powell Testimony - U.S. Commentary.NEWS91: Stocks May Open Roughly Flat Ahead Of Powell Testimony - U.S. Commentary.NEWS92: Stocks Drift, Oil Extends Declines as Investors Question Global Growth Prospects.NEWS93: Johnson & Johnson Q2 18 Earnings Conference Call At 8:30 AM ET.NEWS94: Johnson & Johnson Q2 18 Earnings Conference Call At 8:30 AM ET.NEWS95: Johnson & Johnson Updates FY18 Outlook - Quick Facts.NEWS96: Johnson & Johnson Updates FY18 Outlook - Quick Facts.NEWS97: Johnson & Johnson Q2 adjusted earnings Beat Estimates.NEWS98: Johnson & Johnson Q2 adjusted earnings Beat Estimates.NEWS99: 10 Dow Jones Titans to Buy Now.NEWS100: 10 Dow Jones Titans to Buy Now.
2018-07-18: NEWS1: J&J&apos;s Darunavir-Based Single-Tablet HIV Regimen Gets FDA Nod.NEWS2: Healthcare ETFs in Focus Following JNJ Q2 Results.NEWS3: Healthcare ETFs in Focus Following JNJ Q2 Results.NEWS4: Healthcare ETFs in Focus Following JNJ Q2 Results.NEWS5: Penn, Johnson & Johnson team up to accelerate innovation.NEWS6: Stock Market News For Jul 18, 2018.NEWS7: Rewind: Why Jim Cramer Is Bullish on Johnson & Johnson Shares.NEWS8: Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for July 19, 2018.NEWS9: Zoetis Inc. (ZTS) Ex-Dividend Date Scheduled for July 19, 2018.NEWS10: Benzinga's Daily Biotech Pulse: Novartis Earnings, J&J's HIV Combo Clears FDA Hurdle, Cara To Offer Shares.NEWS11: Today's Research Reports on Stocks to Watch: Johnson & Johnson and Avid Bioservices.NEWS12: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS13: J&J (JNJ) Faces $4.69 Billion Verdict in Talc Case (Revised).NEWS14: J&J (JNJ) Faces $4.69 Billion Verdict in Talc Case (Revised).NEWS15: J&J (JNJ) Faces $4.69 Billion Verdict in Talc Case (Revised).NEWS16: Novartis (NVS) Stock Flat Ahead of Earnings: What To Watch.NEWS17: Novartis (NVS) Stock Flat Ahead of Earnings: What To Watch.NEWS18: Asian stocks rise as solid US performance lifts spirits.NEWS19: Asian stocks rise as solid US performance lifts spirits.NEWS20: What's Behind Johnson & Johnson's Double-Digit Growth?.NEWS21: What's Behind Johnson & Johnson's Double-Digit Growth?.NEWS22: [$$] Johnson & Johnson’s Pharma Business Fuels Sales Growth.NEWS23: Novartis (NVS) Stock Flat Ahead of Earnings: What To Watch.NEWS24: What&apos;s Behind Johnson & Johnson&apos;s Double-Digit Growth?.NEWS25: 5 Top Stock Trades for Wednesday Morning.NEWS26: 5 Top Stock Trades for Wednesday Morning.
2018-07-19: NEWS1: Johnson & Johnson and General Motors: Growth and Income Stocks.NEWS2: Johnson & Johnson and General Motors: Growth and Income Stocks.NEWS3: These 2 Healthcare Giants Had Diverging Short-Term Moves, but Have Parallel Long-Term Stories.NEWS4: These 2 Healthcare Giants Had Diverging Short-Term Moves, but Have Parallel Long-Term Stories.NEWS5: Women who sued J&J declare victory after $4.69 billion talc verdict.NEWS6: Johnson & Johnson and General Motors: Growth and Income Stocks.NEWS7: Women who sued J&J declare victory after $4.69 bln talc verdict.NEWS8: These 2 Healthcare Giants Had Diverging Short-Term Moves, but Have Parallel Long-Term Stories.NEWS9: Edited Transcript of JNJ earnings conference call or presentation 17-Jul-18 12:30pm GMT.NEWS10: Should Investors Be Worried About Netflix, United Health, or Johnson & Johnson?.NEWS11: Should Investors Be Worried About Netflix, United Health, or Johnson & Johnson?.NEWS12: AbbVie shares drop 5.5% after short seller Citron calls it &apos;next great drug short&apos;.NEWS13: Should Investors Be Worried About Netflix, United Health, or Johnson & Johnson?.NEWS14: Free Research Report as Johnson & Johnson's Quarterly Earnings Advanced 14.75%.NEWS15: New Drugs and Expected Growth Could Trigger a Recovery for Celgene Stock.NEWS16: J&J's Darunavir-Based Single-Tablet HIV Regimen Gets FDA Nod.NEWS17: J&J's Darunavir-Based Single-Tablet HIV Regimen Gets FDA Nod.NEWS18: Interpublic's Weber Shandwick Acquires Social Agency That Lot.NEWS19: Interpublic's Weber Shandwick Acquires Social Agency That Lot.
2018-07-20: NEWS1: Analysts’ Estimates and Recommendations for Allergan on July 19.NEWS2: MARKETS: Honeywell stock pops after raising full year guidance.NEWS3: 3 Stocks That Could Be Added to the Dow Next.NEWS4: 3 Stocks That Could Be Added to the Dow Next.NEWS5: Dow 30 Stock Roundup: Goldman Sachs, IBM, J&J, Microsoft Earnings Impress.NEWS6: Dow 30 Stock Roundup: Goldman Sachs, IBM, J&J, Microsoft Earnings Impress.NEWS7: Pharma Stock Roundup: JNJ & NVS' Q2 Earnings, FDA Approvals.NEWS8: Pharma Stock Roundup: JNJ & NVS' Q2 Earnings, FDA Approvals.NEWS9: 3 Stocks That Could Be Added to the Dow Next.NEWS10: Pharma Stock Roundup: JNJ & NVS&apos; Q2 Earnings, FDA Approvals.NEWS11: Dow 30 Stock Roundup: Goldman Sachs, IBM, J&J, Microsoft Earnings Impress.NEWS12: Three Key Takeaways From Healthcare Earnings Season.NEWS13: Women who sued Johnson & Johnson declare victory after $4.69 billion talc verdict.

Answer: Rise